Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer

Carmela Martini, Jessica M. Logan, Alexandra Sorvina, Colin Gordon, Andrew R. Beck, Ben S-Y. Ung, Maria C. Caruso, Courtney Moore, Ashleigh Hocking, Ian R.D. Johnson, Ka Lok Li, Litsa Karageorgos, Ashley M. Hopkins, Adrian J. Esterman, Chelsea Huzzell, Robert D. Brooks, Joanna Lazniewska, Shane M. Hickey, Christie Bader, Emma Parkinson-LawrenceRoberto Weigert, Michael J. Sorich, Prerna Tewari, Cara Martin, Sharon O'Toole, Mark Bates, Mark Ward, Bashir Mohammed, Helen Keegan, William Watson, Sophie Prendergast, Sheena Heffernan, Sarah NiMhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Nathan Brady, Andres Clarke, Filip Sokol, Sarita Prabhakaran, Jürgen Stahl, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Stavros Selemidis, Kim L. Moretti, Lisa M. Butler, John J. O'Leary, Douglas A. Brooks

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
92 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science